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Abstract 
Background: All research has room for improvement, but authors do not always clearly 
acknowledge the limitations of their work. In this brief report, we sought to identify the 
prevalence of limitations statements in the medRxiv COVID-19 SARS-CoV-2 dataset. 
Methods: We combined automated methods with manual review to analyse manuscripts for 
the presence, or absence, either of a defined limitations section in the text, or as part of the 
general discussion.  
Results: We identified a structured limitations statement in 28% of the manuscripts, and 
overall 52% contained at least one mention of a study limitation. Over one-third of 
manuscripts contained none of the terms that might typically be associated with reporting of 
limitations. Overall our method performed with precision of 0.97 and recall of 0.91. 
Conclusion: The presence or absence of limitations statements can be identified with 
reasonable confidence using automated tools. We suggest that it might be beneficial to 
require a defined, structured statement about study limitations, either as part of the 
submission process, or clearly delineated within the manuscript. 
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Introduction 
All research has room for improvement, but authors do not always clearly and specifically 
acknowledge the limitations of their work [1][2]. Previous studies on the reporting of 
limitations in biomedical literature found that over 25% of 300 sampled papers contained no 
limitations [3]; while an earlier study, using automated methods to screen 400 articles for the 
presence of cue words, suggested that 83% did not mention any identifiable limitations 
statements [4]. 
 
To improve dissemination and reporting of the scholarly record, some have argued that 
journals should make authors’ study limitations public and freely available [5]. Typically, 
limitations are detailed in the Discussion section [6], although occasionally they may also 
appear in the Abstract [3]. To standardise recording of limitations, and to make a study’s 
shortcomings more transparent, some have argued that research papers should always have a 
separate, structured section dedicated to this [5]. 
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Inspired by this previous work, and in particular by concerns raised about the rush to publish 
research on COVID-19/SARS-CoV-2 [2], we sought to answer the following questions about 
medical preprints on the novel coronavirus: 
 
• What proportion contain a clear discussion of their limitations?  
• How easy is it to find the discussion of the limitations? 
• Where in the paper are the limitations mentioned? 
 
Since 2019, medRxiv [7] has become the major repository for distribution of unpublished, 
non-peer reviewed literature on medical and health research. We decided to use manuscripts 
posted on medRxiv as the dataset for this brief study. 
Methods 
We took the medRxiv feed of COVID-19 SARS-CoV-2 preprints from 
https://connect.medrxiv.org/relate/content/181 on 24 April 2020, which at the time listed 
1747 manuscripts on the medRxiv server, and around 490 on the related bioRxiv server. We 
selected just the 1747 medRxiv manuscripts.  
 
These manuscripts had been made available on the medRxiv server between 10 January 2020 
and 22 April 2020. All manuscripts were PDF files, ranging in size from < 1MB to over 
35MB. Following [4], our aim was to use automated methods to analyse the manuscripts as 
far as possible, but also follow [3] by cross-checking the automated results with manual 
inspection and verification.  
 
While these medRxiv manuscripts are also available in machine-readable format as part of 
the AllenAI CORD-19 dataset [8], the full-text in that dataset is in the form of body text 
chunks delimited by citation spans, and would have required additional pre-processing to add 
the structure we required (see Discussion). Instead, the manuscripts were processed through 
the Scholarcy API1 to convert the PDFs to structured data in JSON format, which includes 
the full text of the manuscript, structured into the main section headings and their content. 
The API makes use of regular-expression style pattern matchers over spacy.io2 linguistic 
features to identify section headings. It also uses a sentence-level statistical classifier, trained 
on character n-gram features from the PubMed OpenAccess Subset3 to identify funding 
statements, ethical compliance statements, data availability statements, and limitations 
statements. 
 
From the API output, we identified how many manuscripts recorded limitations in a 
structured way in a specific section/subsection by counting the number of section headings 
across the corpus containing the word ‘Limitations’. We also used the output of the API’s 
limitations statement classifier to identify how many manuscripts contained limitations 
statements generally in the text, and in which section these appeared.  We then checked the 
results by hand to calculate the precision and recall of this automated process. 
                                                
1
 https://api.scholarcy.com 
2
 https://spacy.io/usage/linguistic-features 
3
 https://www.ncbi.nlm.nih.gov/pmc/tools/openftlist/ 
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Results 
The section-heading extraction identified 516 ‘limitations’-type headings, subheadings, or 
run-in headings/paragraph starts in 494 manuscripts (28%). Manual inspection revealed that 
22 of these were false positives, which results in a precision of 1- 22/516 = 0.96. 
 
The limitations classifier identified 930 limitations statements across 834 manuscripts (48%). 
Manual inspection revealed that 28 of these were false positives, which gives us a precision 
score of 1- 28/930 = 0.97. 
 
We reviewed the remaining manuscripts to see how many did in fact contain limitations 
mentions that were missed by the automated extraction process. Of these 913 manuscripts, 
we found, by manual inspection, a discussion of limitations in only 83, which gives us a 
combined limitations headings extraction + limitations classifier recall of 1 - 83/913 = 0.91. 
 
Table 1 provides a breakdown of the location of limitations statements. In some manuscripts, 
limitations are restated in the abstract. 
 
Table 1: Where are limitations statements located? 
Location Number of manuscripts 
Defined heading 494 
Results/Discussion/Conclusion 387 
Abstract 11 
Other (non-standard section headings or 
elsewhere in the text) 
36 
 
Table 2 shows a representative sample of limitations statements missed by the classifier. 
 
Table 2: Examples of limitations not identified by automated processing 
We conclude with a word of caution 
We are certainly no experts in this field and a GM is simply a description of a smooth time 
evolution of infections 
We leave it to the reader to treat the here presented observations and claims with enough 
care 
We recognize that our data source is useful and timely but should not replace official 
statistics 
One significant factor that could invalidate the predictions 
Our results should be interpreted in relative terms 
Our findings are constrained to a limited time frame and might have missed time-changing 
disease accounting for the limited follow-up duration 
This study is a cross-sectional study, which only described and analyzed COVID-19 
patients with positive real-time RT-PCR results 
Take the exact figures obtained with our simulations with a grain of salt 
Our results are based on data for a single, large country 
Caveats: these are preliminary results 
We caution that the data are sparse 
Reported data may not be accurate 
Our model should be used with extreme caution 
The results do strongly depend on limitations on data collection 
Due to shortcomings in the reported data 
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A word of caution concerning the present view: any model is but an imperfect view of 
reality 
 
 
It seemed surprising to us that 913-83 = 830 manuscripts (48%) appeared to contain no clear 
mention of limitations, so as a sanity check, we ran a search across these to see if we had 
missed anything obvious. We searched for any combination of one or more of the words: 
 
limitations, limitation, shortcomings, shortcoming, caution, defects, defect, 
weaknesses, weakness, deficiencies, deficiency, future research, future work, future 
studies, future study, further research, further work, further studies, further study 
 
across the full text within the JSON data. Yet 616 manuscripts (35%) contained none of these 
words. 
Discussion 
In the medRxiv COVID-19 SARS-CoV-2 snapshot, we found limitations statements in 917 
of the 1747 preprints - just over 52%. While undoubtedly some of the remainder probably did 
contain limitations statements, but we failed to find them, the fact that 35% of the total 
contained none of the words you might expect to appear at least once, somewhere in the 
paper, suggests that our results align with the 2013 study by Ter Riet et al [3]. 
 
It would be interesting to repeat this analysis over the larger CORD-19 dataset [8]. This 
dataset contains a combined bioRxiv/medRxiv subset which, at the time of writing, contained 
2,278 JSON files4. In fact, a quick scan of this dataset reveals a similar paucity of defined 
limitations sections as found in the analysis of our own automated processing: searching the 
CORD-19 subset using the regular expression (case-insensitive): 
 
"section": "[^"]*Limitations  
 
reveals matches in only 106 of the 2278 manuscripts (~5%), and 950 (42%) contain none of 
the sanity-check word-search terms. 
 
The precision and recall of our automated limitations-statement classifier (0.97, 0.91, 
respectively; F1=0.94), which combines a pattern-based approach with machine learning, is 
similar to that of the tool developed and reported by [9]. It appears that, if a limitations 
statement is present, it should be reasonably straightforward to identify it in the text using an 
automated approach. Future work should verify whether these results hold for a much larger 
dataset of manuscripts than the one considered here. 
 
The dataset comprised unreviewed preprints that represent preliminary, breaking research. 
Those preprints that go on to journal submission and peer review are likely to go through a 
number of revisions that may make the reporting of limitations more explicit and clearly 
defined. But if preliminary research is to be put in the public domain, is it enough to add a 
‘treat with caution’ disclaimer? Shouldn’t it be good practice, even with the need to 
accelerate publication during a crisis, for authors to lay out study limitations clearly and 
specifically, particularly as preprint findings start to be reported in the mainstream media? 
 
                                                
4
 https://ai2-semanticscholar-cord-19.s3-us-west-2.amazonaws.com/latest/biorxiv_medrxiv.tar.gz 
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Whether limitations belong in their own, labelled (sub)section is a decision for reviewers, 
journal editors and the wider research community. However, for someone screening 
preprints, it might make the job easier if these are clearly identifiable - almost as metadata - 
in the same way that other information such as funding, acknowledgements, data availability 
and conflicts of interests tend to be declared in a manuscript. 
Limitations 
Only one author checked the automated identification of limitations statements extraction. 
The author is not a domain expert and so may not have picked up all limitations where they 
were not clearly expressed. Also, presence or absence of a limitations statement was checked 
against document text contained within the machine-extracted JSON data, but not against 
original manuscript PDF. It is possible that in some cases, the text extraction may not have 
extracted the complete article content. However, this risk was mitigated by performing post-
hoc checks against the CORD-19 dataset [8]. Finally, the sanity-check search may not have 
been comprehensive, and limitations may have been stated in a more implicit way that 
required domain knowledge to interpret. As a result, the recall figure of the automated 
process may be lower, and the proportion of manuscripts in this collection that do in fact state 
their limitations may be higher than that reported here. Close reading of the original 
manuscripts by multiple domain experts would reveal a more accurate estimate of the 
prevalence of limitations statements, similar to [9]. 
Conclusion 
We used automated processing combined with manual review to estimate the prevalence of 
clearly identifiable limitations statements in the medRxiv corpus of COVID-19 SARS-CoV-2 
preprints. We found that around half of them did not appear to contain such a statement, and 
just over a third of them contained none of the words that might be associated with reporting 
of limitations. We suggest that it might be beneficial to require a defined, structured 
statement about study limitations, either as part of the submission process, or clearly 
delineated within the manuscript. 
 
Data availability 
The 24 April 2020 medRxiv COVID-19 dataset of 1747 PDF URLs, and the corresponding 
API output for each PDF, is available from the authors. As the copyright of the full text of 
each manuscript is with each author, and our analysis required full-text PDF extraction, we 
are unable to make the extracted full-text data publicly available. However, the Scholarcy 
API is available for those who wish to re-run the extraction from the list of URLs5, and 
machine-readable versions of these papers, albeit in a different format, are available as part of 
the CORD-19 Dataset [8]. 
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